Who We Are

The Medicines Patent Pool (MPP) is a United Nations-backed public health organisation working to increase access to, and facilitate the development of, life-saving medicines for low- and middle-income countries.

MedsPaL

The Medicines Patents & Licences Database
The MPP’s patents and licences database, MedsPaL, is a resource that provides information on the intellectual property status of selected HIV, hepatitis C, tuberculosis and other patented essential medicines in low- and middle-income countries.

Transparency

All MPP licences are publicly available in their entirety on our website. This is unprecedented in the pharmaceutical field.

MPP in Numbers

Hover over the numbers to find out more
9
9 patent holders with MPP signed agreements
17
17 million patient-years through MPP’s generic partners from January 2012 to December 2017
24
24 generic manufacturers and product developers sublicensed from the MPP
18
18 products licensed to the MPP
130+
130+ ongoing pharmaceutical development projects
87% to 91%
87% to 91% of people living with HIV in developing countries covered by the MPP adult licences
92 to 131
92 to 131 countries covered by MPP adults licences
553
553 million dollars saved, from January 2012 to December 2017

Latest News

Videos

See More

Endorsements

See More
“Central to our vision at AbbVie is developing therapies, such as our pan-genotypic HCV treatment, for the most serious diseases and providing access to those treatments. We are pleased to have reached today’s agreement [Licence agree...”

This website uses cookies to ensure you get the best experience on our website. Learn More